Good morning, and welcome to the Duluth Holdings fourth-quarter 2024 financial results conference call. All participants will be in listen-only mode. [Operator instructions] Please note that there will not be a Q&A session following this presentation.

Q4 2024 Earnings Call Transcript March 12, 2025 InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.2. Operator: Hello and welcome to InspireMD’s fourth quarter 2024 earnings conference call.

Thank you for attending today's SentinelOne Q4 fiscal year 2025 earnings conference call. My name is Jaeleen, and I will be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.

Greetings, and welcome to Redfin Corporation Quarter 4 2024 earnings conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded.

Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, expectations were $0.25. Operator: Good morning, everyone, and thank you for joining OptimizeRx’s Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call.

Q4 2024 Earnings Call Feb 28, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepared

Organogenesis ( ORGO -5.54%) Q4 2024 Earnings Call Feb 27, 2025, 5:00 p.m. ET

Operator: Good morning and welcome to Agenus Inc.’s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all participants are in a listen-only mode. A question-and-answer session will follow the formal remarks. As a reminder, this conference is being recorded. I will now turn the call over to Zack Armen, Head of Investor Relations.